Sonova's Board of Directors nominates Dr. Beat Hess as a new board member
"It is with great pleasure that we propose Dr. Beat Hess as a new member to the Board of Directors. With his international and broad legal experience, including in the areas of corporate governance, compliance and risk management, Dr. Beat Hess complements the current Board of Directors perfectly" says Robert Spoerry, Chairman of the Board of Directors of Sonova Holding AG. Dr. Beat Hess (born in 1949), Swiss citizen, studied at the Universities of Geneva, Freiburg and Miami, is an attorney-at-law and holds a Ph.D in Law. From 1988 to 2003, Dr. Beat Hess served as General Counsel of ABB Group and, from 2003 to 2011, as Group Legal Director and Member of the Group Executive Committee of Royal Dutch Shell plc. Dr. Beat Hess is a member of the Board of Directors of Nestlé S.A. and of Holcim Ltd.
As already communicated, William D. Dearstyne who has served on the Board of Sonova Holding AG for many years, will retire at the 2012 Annual General Meeting. The organizational regulations of Sonova Holding AG provide for an automatic retirement at the Annual General Meeting following the completion of the 70th year of age. The Board of Directors, for the reasons explained in the invitation to the 2011 Annual General Meeting and pursuant to the exception clause in the organizational regulations, granted an extension to William D. Dearstyne's term of office for one year, until the Annual General Meeting in June 2012.
This Media Release may contain forward-looking statements which offer no guarantee with regard to future performance. These statements are made on the basis of management's views and assumptions regarding future events and business performance at the time the statements are made. They are subject to risks and uncertainties including, but not confined to, future global economic conditions, exchange rates, legal provisions, market conditions, activities by competitors and other factors outside the company's control.
Sonova Holding AG
Sonova is the leading provider of innovative hearing healthcare solutions. The globally active group is the world's top manufacturer of hearing systems, the market leader in wireless communication systems for audiology applications, develops and manufactures advanced cochlear implant systems and provides professional solutions for hearing protection. Sonova is pursuing a clear growth strategy and is intent to grow faster than the market. To this end it is constantly expanding its existing business segments and branching out into other areas of the hearing healthcare industry. Present in over 90 countries, and with a workforce of over 7,800 employees, Sonova generated sales of CHF 1.6 billion in the financial year 2010/11 and a net profit of CHF 231 million. This financially strong group of companies bases its success on innovation, customer focus and proactive cost management. The company has been successfully promoting understanding and communication for over 60 years, and is ideally positioned to benefit from the trends in this growth industry.
For more information please visit www.sonova.com.
Sonova shares (ticker symbol:SOON) have been listed on the SIX Swiss Exchange since 1994. The securities of Sonova have not been and will not be registered under the U.S. Securities Act and may not be offered or sold in the United States of America except pursuant to an exemption from the registration requirements under the U.S. Securities Act, or outside the United States of America in reliance on Regulation S under the U.S. Securities Act.